Stay updated on Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial page.

Latest updates to the Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdministrative update: Revision v3.4.2 has been added and Revision v3.4.1 removed. No study content or user-facing functionality is affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH operating status was added to the page, directing users to cc.nih.gov and opm.gov. The page revision label updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedThe page now shows a glossary, adds a QC update label, includes a No FEAR Act Data link, and updates the revision notice to v3.4.0. The older capitalization variant of QC criteria and the previous revision entry were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows Revision: v3.3.4 instead of v3.3.3 as a minor update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 has been added and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' have been removed from the page footer. These are minor administrative UI updates that do not affect the study details or user actions on this page.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page now shows a revision tag: v3.3.2, replacing the prior v3.3.1. The study details appear unchanged.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial page.